Amarin Corporation PLC AMRN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
0.88quote price arrow up+0.0095 (+1.092%)
Volume
14,000
Close
0.87quote price arrow down-0.0424 (-4.6471%)
Volume
962,361
52 week range
0.65 - 1.49
Loading...
  • Open0.9025
  • Day High0.9125
  • Day Low0.87
  • Prev Close0.9124
  • 52 Week High1.49
  • 52 Week High Date07/18/23
  • 52 Week Low0.65
  • 52 Week Low Date11/01/23

Key Stats

  • Market Cap357.456M
  • Shares Out410.87M
  • 10 Day Average Volume0.94M
  • Dividend-
  • Dividend Yield-
  • Beta2.00
  • YTD % Change-

KEY STATS

  • Open0.9025
  • Day High0.9125
  • Day Low0.87
  • Prev Close0.9124
  • 52 Week High1.49
  • 52 Week High Date07/18/23
  • 52 Week Low0.65
  • 52 Week Low Date11/01/23
  • Market Cap357.456M
  • Shares Out410.87M
  • 10 Day Average Volume0.94M
  • Dividend-
  • Dividend Yield-
  • Beta2.00
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.13
  • P/E (TTM)-6.75
  • Fwd P/E (NTM)-5.54
  • EBITDA (TTM)-22.922M
  • ROE (TTM)-9.30%
  • Revenue (TTM)277.455M
  • Gross Margin (TTM)63.61%
  • Net Margin (TTM)-18.96%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date07/31/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Amarin Corporation PLC

 

Profile

MORE
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the...
Odysseas Kostas M.D.
Non-Executive Independent Chairman of the Board
Patrick Holt
President, Chief Executive Officer, Director
Thomas Reilly
Chief Financial Officer, Executive Vice President, Global Head of HR, Principal Accounting Officer
Jonathan Provoost
Executive Vice President, Chief Legal and Compliance Officer, Secretary
Aaron Berg
Executive Vice President, President - US
Address
Gemini House, Bartholomews Walk
Dublin
FK7 9JQ
Ireland

Top Peers

SYMBOLLASTCHG%CHG
VNDA
Vanda Pharmaceuticals Inc
5.48-0.10-1.79%
ESPR
Esperion Therapeutics Inc
2.36-0.23-8.88%
TVTX
Travere Therapeutics Inc
6.06-0.63-9.42%
PROC
Procaps Group SA
2.88+0.30+11.63%
CSTL
Castle Biosciences Inc
24.24+0.02+0.08%